sorafenib has been researched along with 5,7-dimethoxyflavone in 1 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (5,7-dimethoxyflavone) | Trials (5,7-dimethoxyflavone) | Recent Studies (post-2010) (5,7-dimethoxyflavone) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 64 | 0 | 38 |
Protein | Taxonomy | sorafenib (IC50) | 5,7-dimethoxyflavone (IC50) |
---|---|---|---|
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 9.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
An, G; Bae, S; D'Cunha, R; Shao, J | 1 |
1 other study(ies) available for sorafenib and 5,7-dimethoxyflavone
Article | Year |
---|---|
Effect of 5,7-dimethoxyflavone on Bcrp1-mediated transport of sorafenib in vitro and in vivo in mice.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biological Transport; Dogs; Drug Interactions; Drug Resistance, Neoplasm; Flavonoids; LLC-PK1 Cells; Madin Darby Canine Kidney Cells; Male; Mice; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Sorafenib; Swine; Tissue Distribution | 2018 |